Stronger Together
Thank you to everyone who voted and helped us decide how to split our donation supporting Breast Cancer Awareness month. See below for the final results.*
Why Choose Onco360?
- #1 in patient and provider satisfaction**
- Financial assistance sourcing available for qualified patients
- Clinical programs developed by Board-Certified Oncology Pharmacists
- Free overnight delivery to a patient’s doorstep
Onco360 dispenses these common breast cancer medications***
Abraxane® (protein-bound paclitaxel)
Adriamycin® (doxorubicin)
Afinitor® (everolimus)
Arimidex® (anastrozole)
Aromasin® (exemestane)
Cytoxan® (cyclophosphamide)
Ellence® (epirubicin)
Enhertu® (fam-trastuzumab deruxtecan)
Faslodex® (fulvestrant)
Femara® (letrozole)
Gemzar® (gemcitabine)
Halaven® (eribulin)
Herceptin® (trastuzumab)
Ibrance® (palbociclib)
Ixempra® (ixabepilone)
Jemperli (dostarlimab)
Kadcyla® (ado-trastuzumab emtansine)
Keytruda® (pembrolizumab)
Kisqali® (ribociclib)
Margenza® (margetuximab)
Nerlynx® (neratinib)
Perjeta® (pertuzumab)
Piqray® (alpelisib)
Rozlytrek® (entrectinib)
Soltamox™ (tamoxifen)
Talzenna® (talazoparib)
Taxol® (paclitaxel)
Taxotere® (docetaxel)
Trexall® (methotrexate)
Tukysa® (tucatinib)
Tykerb® (lapatinib)
Verzenio® (abemaciclib)
Xeloda® (capecitabine)
Zoladex® (goserelin)
If you are a provider and would like to refer to Onco360, click here for order forms.
*Onco360 donated $10,000 during the month of October 2022. The general public had the option to vote for three charities: Living Beyond Breast Cancer, The National Breast Cancer Foundation, and breastcancer.org. The final donation was based on the percentage split of votes.
**Third-party survey data provided by MMIT for Independent Specialty Pharmacies (Oncology). Report Dates: Q3 and Q4 2021
***This list is a small portion of the comprehensive medications Onco360 can provide